/
ACBD
$0.84+$0.74 (+723.53%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.05 – $1.41
58% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$0.34
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $62.5K | $75.0K | $1.5K | $10.0K | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $62.5K | $75.0K | $1.5K | $10.0K | $0 | $0 |
| Gross margin | — | — | 100.0% | 100.0% | 100.0% | 100.0% | — | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$164.8K | −$131.2K | −$42.5K | $64.6K | −$13.5K | −$10.0K | −$130.5K | −$18.0K |
| EBITDA | −$164.8K | $40.7K | −$42.5K | $64.6K | −$13.5K | $157.9K | −$130.5K | −$18.0K |
| Net income | −$164.8K | −$131.2K | −$42.5K | $64.6K | −$13.5K | −$10.0K | −$130.5K | −$18.0K |
| Net margin | — | — | -68.0% | 86.1% | -902.3% | -100.3% | — | — |
| EPS (diluted) | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
Annual figures · source: Financial Modeling Prep
Peer comparison
ANNABIDIOL CORP
ANNABIDIOL CORP
Held by traders on TradeandTell
No one on the platform currently holds ACBD.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ACBD as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ACBD yet.